---
title: "Sotalol - Atrial Fibrillation"
sidebar: mydoc_sidebar
permalink: db00489-mesh-d001281-1.html
toc: false 
---


Path ID: `DB00489_MESH_D001281_1`
{% include image.html url="images/db00489-mesh-d001281-1.png" file="db00489-mesh-d001281-1.png" alt="db00489-mesh-d001281-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D013015">MESH:D013015 </a> | Sotalol | Drug |
| <a href="https://identifiers.org/UniProt:P08588">UniProt:P08588 </a> | Beta-1 adrenergic receptor | Protein |
| <a href="https://identifiers.org/UniProt:P07550">UniProt:P07550 </a> | Beta-2 adrenergic receptor | Protein |
| <a href="https://identifiers.org/UniProt:Q12809">UniProt:Q12809 </a> | Potassium voltage-gated channel subfamily H member 2 | Protein |
| <a href="https://identifiers.org/GO:0005245">GO:0005245 </a> | voltage-gated calcium channel activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0005249">GO:0005249 </a> | voltage-gated potassium channel activity | MolecularActivity |
| <a href="https://identifiers.org/GO:0060047">GO:0060047 </a> | voltage-gated calcium channel activity | BiologicalProcess |
| <a href="https://identifiers.org/HP:0031860">HP:0031860 </a> | Abnormal heart rate variability | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D001281">MESH:D001281 </a> | Atrial Fibrillation | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Sotalol | DECREASES ACTIVITY OF | Beta-1 Adrenergic Receptor |
| Sotalol | DECREASES ACTIVITY OF | Beta-2 Adrenergic Receptor |
| Sotalol | DECREASES ACTIVITY OF | Potassium Voltage-Gated Channel Subfamily H Member 2 |
| Beta-1 Adrenergic Receptor | POSITIVELY REGULATES | Voltage-Gated Calcium Channel Activity |
| Beta-2 Adrenergic Receptor | POSITIVELY REGULATES | Voltage-Gated Calcium Channel Activity |
| Potassium Voltage-Gated Channel Subfamily H Member 2 | POSITIVELY REGULATES | Voltage-Gated Potassium Channel Activity |
| Voltage-Gated Calcium Channel Activity | POSITIVELY CORRELATED WITH | Voltage-Gated Calcium Channel Activity |
| Voltage-Gated Potassium Channel Activity | POSITIVELY CORRELATED WITH | Voltage-Gated Calcium Channel Activity |
| Voltage-Gated Calcium Channel Activity | POSITIVELY CORRELATED WITH | Abnormal Heart Rate Variability |
| Abnormal Heart Rate Variability | CONTRIBUTES TO | Atrial Fibrillation |
|---------|-----------|---------|

Reference: 
  - [https://go.drugbank.com/drugs/DB00489#mechanism-of-action](https://go.drugbank.com/drugs/DB00489#mechanism-of-action)
  - [https://en.wikipedia.org/wiki/Sotalol#Mechanisms_of_action](https://en.wikipedia.org/wiki/Sotalol#Mechanisms_of_action)
  - [https://www.uniprot.org/uniprot/P08588#function](https://www.uniprot.org/uniprot/P08588#function)
  - [https://www.uniprot.org/uniprot/P07550#function](https://www.uniprot.org/uniprot/P07550#function)
  - [https://www.uniprot.org/uniprot/Q12809#function](https://www.uniprot.org/uniprot/Q12809#function)
  - [https://en.wikipedia.org/wiki/Atrial_fibrillation](https://en.wikipedia.org/wiki/Atrial_fibrillation)
